Ranmark subcutaneous injection 120mg, from Daiichi Sankyo, contains denosumab (genetical recombination). It is used for treating bone complications associated with multiple myeloma and bone metastases from solid tumors. This product is a 120mg 1.7mL 1 bottle with YJ code 3999435A1020.
Ranmark subcutaneous injection 120mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →